Open AccessBisoprolol in treatment of arterial hypertension in pregnant women
Author(s) -
Р. И. Стрюк
Publication year - 2019
Publication title -
medicinskij alfavit
Language(s) - English
Resource type - Journals
eISSN - 2949-2807
pISSN - 2078-5631
DOI - 10.33667/2078-5631-2019-2-27(402)-32-34
Subject(s) - bisoprolol , medicine , pregnancy , fetus , drug , beta (programming language) , food and drug administration , obstetrics , anesthesia , blood pressure , pharmacology , genetics , computer science , biology , programming language
Summary In pregnant women with different clinical options for arterial hypertension, highly selective beta-blockers may be the drugs of choice from the second trimester of pregnancy. The drugs of this group according to the FDA (US Food and Drug Administration) are classified as category C. Their purpose corresponds to the principle of risks and benefits. One of the highly effective and safe drugs in this group is bisoprolol. However, for early detection of the possible negative effects of beta-blockers on the fetus (a newborn), the probability of occurrence of which is extremely low, it is advisable to monitor the vital functions of the fetus (a newborn), the level of glycemia.